Carlos Malpica was trained in France at Institut National Agronomique Paris-Grignon and Pasteur Institute. He obtained his PhD. in Biotechnology from Paris University 7. He also holds a diploma from the Spanish Diplomatic School and an International Executive MBA from Instituto de Empresa (Spain).
Dr. Malpica is the CEO of MLP Vision Biotech S.L. and is currently involved in establishing Valdia Health in Qatar. For the last seven years he was actively promoting global adoption of metabolomics technologies as Global Business Development Director at Metabolon Inc. (USA). Other past activities include Marketing and Sales Director at Biopolis S.L. (Spain), Research Director at L’Oréal Group (France), CEO of Kina Biotech S.L. (Spain), Global Business Development Manager at Syngenta A.G. (Switzerland), Head of Business Development Europe at Novartis Seeds S.A.S. (France) and Biotechnology Research Coordinator at the DANONE Group (France).